Mary T. Bessesen

Dr. Mary T. Bessesen

orcid

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 May 2010 in PLOS ONE
Verified
Journal Article
Open access
PDF file
DFDaniel N. Frank
Daniel N. Frank
LFLeah M. Feazel
Leah M. Feazel
MBMary T. Bessesen
Mary T. Bessesen
CPConnie S. Price
Connie S. Price
EJEdward N. Janoff
Edward N. Janoff
NPNorman R. Pace
Norman R. Pace
Colonization of humans with Staphylococcus aureus is a critical prerequisite of subsequent clinical infection of the skin, blood, lung, heart and other deep tissues. S. aureus persistently or intermittently colonizes the nares of ∼50% of healthy adults, whereas ∼50% of the general population is rarely or never colonized by this pathogen. Because microbial consortia within the nasal cavity may be an important determinant of S. aureus colonization we determined the composition and dynamics of the nasal microbiota and correlated specific microorganisms with S. aureus colonization. Nasal specimens were collected longitudinally from five healthy adults and a cross-section of hospitalized patients (26 S. aureus carriers and 16 non-carriers). Culture-independent analysis of 16S rRNA sequences revealed that the nasal microbiota of healthy subjects consists primarily of members of the phylum Actinobacteria (e.g., Propionibacterium spp. and Corynebacterium spp.), with proportionally less representation of other phyla, including Firmicutes (e.g., Staphylococcus spp.) and Proteobacteria (e.g. Enterobacter spp). In contrast, inpatient nasal microbiotas were enriched in S. aureus or Staphylococcus epidermidis and diminished in several actinobacterial groups, most notably Propionibacterium acnes. Moreover, within the inpatient population S. aureus colonization was negatively correlated with the abundances of several microbial groups, including S. epidermidis (p = 0.004). The nares environment is colonized by a temporally stable microbiota that is distinct from other regions of the integument. Negative association between S. aureus, S. epidermidis, and other groups suggests microbial competition during colonization of the nares, a finding that could be exploited to limit S. aureus colonization.

6 August 2013 in Clinical Infectious Diseases
Verified
Journal Article
Closed access
PDF file
ACAylin Colpan
Aylin Colpan
BJBrian Johnston
Brian Johnston
SPStephen Porter
Stephen Porter
CCConnie Clabots
Connie Clabots
RARuth Anway
Ruth Anway
ESEdwin Swiatlo
Edwin Swiatlo
Background. Escherichia coli sequence type 131 (ST131), typically fluoroquinolone-resistant (FQ-R) and/or extended-spectrum β-lactamase (ESBL)–producing, has emerged globally. We assessed its prevalence and characteristics among US veterans. Methods. In 2011, 595 de-identified E. coli clinical isolates were collected systematically within 3 resistance groups (FQ-susceptible [FQ-S], FQ-R, and ESBL-producing) from 24 nationally distributed Veterans Affairs Medical Centers (VAMCs). ST131 and its H30 subclone were detected by polymerase chain reaction and compared with other E. coli for molecular traits, source, and resistance profiles. Results. ST131 accounted for 78% (184/236) of FQ-R and 64.2% (79/123) of ESBL-producing isolates, but only 7.2% (17/236) of FQ-S isolates (P < .001). The H30 subclone accounted for ≥95% of FQ-R and ESBL-producing, but only 12.5% of FQ-S, ST131 isolates (P < .001). By back-calculation, 28% of VAMC E. coli isolates nationally represented ST131. Overall, ST131 varied minimally in prevalence by specimen type, inpatient/outpatient source, or locale; was the most prevalent ST, followed distantly by ST95 and ST12 (13% each); and accounted for ≥40% (β-lactams), >50% (trimethoprim-sulfamethoxazole , multidrug), or >70% (ciprofloxacin, gentamicin) of total antimicrobial resistance. FQ-R and ESBL-producing ST131 isolates had higher virulence scores than corresponding non-ST131 isolates. ST131 pulsotypes overlapped extensively among VAMCs. Conclusions. Among US veterans, ST131, primarily its H30 subclone, accounts for most antimicrobial-resistant E. coli and is the dominant E. coli strain overall. Possible contributors include multidrug resistance, extensive virulence gene content, and ongoing transmission. Focused attention to ST131, especially its H30 subclone, could reduce infection-related morbidity, mortality, and costs among veterans.

1 May 1999 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
MBMary T. Bessesen
Mary T. Bessesen
DIDavid Ives
David Ives
LCLynn Condreay
Lynn Condreay
SLSteven Lawrence
Steven Lawrence
KSKenneth E. Sherman
Kenneth E. Sherman
Lamivudine is a nucleoside analog with activity against human immunodeficiency virus (HIV) and hepatitis B virus (HBV). Patients coinfected with HIV

1 August 2010 in American Journal of Infection Control
Verified
Journal Article
Closed access
KGKaren Guerin
Karen Guerin
JWJulia Wagner
Julia Wagner
KRKeith Rains
Keith Rains
MBMary T. Bessesen
Mary T. Bessesen

27 February 1995 in Archives of internal medicine (1960)
Verified
Journal Article
Closed access
PDF file
MPMarc Pechère
Marc Pechère
MOMilos Opravil
Milos Opravil
AWAnna Wald
Anna Wald
JCJean-Philippe Chave
Jean-Philippe Chave
MBMary T. Bessesen
Mary T. Bessesen
BHBernard Hirschel
Bernard Hirschel
Objectives: To characterize clinical and epidemiologic features of infections withMycobacterium genavense. Design: Case series and case-control studies. Patients withM genavensewere compared with two control groups: CD4 controls were matched on the basis of CD4 counts, andMycobacterium avium-intracellularecomplex controls had disseminated infection withM avium-intracellularecomplex. Results: Fifty-four patients with disseminated infections caused byM genavensewere found, from Europe (37), North America (15), and Australia (two). All were infected with human immunodeficiency virus. The median CD4 count was 0.016× 109/L (16/mm3) (range, 0.001 to 0.082×109/L. Eighty-seven percent had fever and weight loss, 44% had diarrhea, 43% had splenomegaly, 39% had hepatomegaly, and 72% had anemia. In Swiss university hospitals,M genavensewas responsible for 12.8% of nontuberculous disseminated mycobacterial infections in patients with human immunodeficiency virus from 1990 to 1992. The median survival was 190 days after the first isolation ofM genavense. Among the patients who had been treated with at least two antimycobacterial drugs for 1 month or more, median survival was 263 days (95% confidence interval, 144 to 382 days), compared with 81 days (95% confidence interval, 73 to 89 days) for those not treated (P=.0009). Survival in patients withM genavensewas similar to the survival ofM avium-intracellularecomplex controls. However, patients with similar CD4 counts (CD4 controls) survived longer (median, 342 days; 95% confidence interval, 269 to 415 days;P<.0003). Conclusions: Infection withM genavensemay be responsible for more than 10% of disseminated nontuberculous mycobacterial infections in patients with human immunodeficiency virus infection. Its clinical presentation and response to treatment are similar to those of infection withM avium-intracellulare complex. (Arch Intern Med. 1995;155:400-404)

1 August 2010 in Critical Care Medicine
Verified
Journal Article
Closed access
JAJudith Anderson
Judith Anderson
LGLaura Lin Gosbee
Laura Lin Gosbee
MBMary T. Bessesen
Mary T. Bessesen
LWLinda Williams
Linda Williams
Human factors engineering is a discipline that studies the capabilities and limitations of humans and the design of devices and systems for improved performance. The principles of human factors engineering can be applied to infection prevention and control to study the interaction between the healthcare worker and the system that he or she is working with, including the use of devices, the built environment, and the demands and complexities of patient care. Some key challenges in infection prevention, such as delayed feedback to healthcare workers, high cognitive workload, and poor ergonomic design, are explained, as is how human factors engineering can be used for improvement and increased compliance with practices to prevent hospital-acquired infections.